| Literature DB >> 25117818 |
R Del Risco Kollerud1, K G Blaasaas2, B Claussen3.
Abstract
BACKGROUND: Over the past few years, there has been growing interest in assessing the relationship between exposure to radon at home and the risk of childhood cancer. Previous studies have produced conflicting results, probably because of limitations assessing radon exposure, too few cancer cases and poorly documented health statistics.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25117818 PMCID: PMC4183841 DOI: 10.1038/bjc.2014.400
Source DB: PubMed Journal: Br J Cancer ISSN: 0007-0920 Impact factor: 7.640
Figure 1The study region in south central Norway contains 4 counties, 15 municipalities and is referred to as the Oslo region in this study.
Figure 2The house in the centre represents a dwelling without radon value, and the circle is the associated buffer. Black points represent dwellings with indoor radon measurements.
Figure 3Annual incidence of leukaemia across age groups in 1967–2003.
Figure 4Annual incidence of cancer in the CNS across age groups in 1967–2003.
Crude and adjusted OR and HR (95% confidence interval) for all leukaemia, acute lymphoblastic leukaemia, CNS cancers and both types across radon exposure level and age in two models across age groups
| | | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All lleukaemia | <50 | 99 | Ref. | Ref. | Ref. | 99 | Ref. | Ref. | Ref. | 95 | Ref. | Ref. | Ref. |
| | 50–100 | 205 | 1.21 (0.95–1.54) | 1.15 (0.90–1.48) | 1.12 (0.88–1.44) | 207 | 1.12 (0.88–1.42) | 1.07 (0.84–1.37) | 1.04 (0.81–1.34) | 209 | 1.05 (0.82–1.33) | 1.00 (0.78–1.29) | 0.97 (0.76–1.25) |
| | >100 | 127 | 1.18 (0.91–1.55) | 1.13 (0.87–1.48) | 1.11 (0.85–1.46) | 125 | 1.10 (0.84–1.43) | 1.07 (0.82–1.40) | 1.05 (0.800–1.37) | 127 | 1.06 (0.82–1.39 | 1.03 (0.79–1.36) | 1.02 (0.78–1.34) |
| | Per 100 Bq m−3 | | 1.00 (0.87–1.14) | 0.99 (0.87–1.14) | 1.00 (0.87–1.14) | | 0.99 (0.86–1.13) | 0.99 (0.86–1.13) | 0.99 (0.86–1.14) | | 0.99 (0.86–1.13) | 0.99 (0.86–1.14) | 1.00 (0.87–1.15) |
| Acute lymphoblastic leukaemia | <50 | 79 | Ref. | Ref. | Ref. | 78 | Ref. | Ref. | Ref. | 74 | Ref. | Ref. | Ref. |
| | 50–100 | 153 | 1.13 (0.86–1.49) | 1.08 (0.82–1.43) | 1.03 (0.78–1.36) | 155 | 1.06 (0.81–1.39) | 1.02 (0.77–1.35) | 0.97 (0.74–1.29) | 157 | 1.01 (0.76–1.33) | 0.97 (0.73–1.28) | 0.93 (0.70–1.23) |
| | 100 | 92 | 1.07 (0.80–1.46) | 1.04 (0.77–1.41) | 1.02 (0.75–1.39) | 91 | 1.02 (0.75–1.37) | 0.98 (0.72–1.34) | 1.00 (0.70–1.31) | 93 | 1.00 (0.74–1.36) | 0.70 (0.71–1.32) | 0.95 (0.69–1.29) |
| | Per 100 Bq m−3 | | 0.97 (0.83–1.14) | 0.97 (0.83–1.14) | 0.98 (0.83–1.15) | | 0.96 (0.82–1.13) | 0.96 (0.23–1.13) | 0.97 (0.82–1.14) | | 0.97 (0.82–1.14) | 0.97 (0.82–1.14) | 0.97 (0.83–1.15) |
| CNS cancer | <50 | 100 | Ref. | Ref. | Ref. | 98 | Ref. | Ref. | Ref. | 92 | Ref. | Ref. | Ref. |
| | 50–100 | 172 | 1.00 (0.79–1.29) | 0.95 (0.74–1.23) | 0.96 (0.74–1.24) | 174 | 0.95 (0.74–1.22) | 0.90 (0.70–1.16) | 0.90 (0.69–1.16) | 182 | 0.94 (0.73–1.21) | 0.88 (0.68–1.14) | 0.88 (0.68–1.14) |
| | >100 | 145 | 1.34 (1.04–1.73) | 1.25 (0.96–1.62) | 1.27 (0.97–1.65) | 145 | 1.29 (1.00–1.66) | 1.22 (0.94–1.59) | 1.21 (0.93–1.58) | 143 | 1.23 (0.95–1.60) | 1.16 (0.89–1.51) | 1.15 (0.87–1.50) |
| | Per 100 Bq m−3 | | 1.17 (1.04–1.32) | 1.14 (1.00–1.29) | 1.13 (1.00–1.29) | | 1.17 (1.04–1.32) | 1.14 (1.00–1.29) | 1.14 (1.00–1.29) | | 1.15 (1.02–1.30) | 1.12 (0.99–1.27) | 1.13 (0.99–1.28) |
| Leukaemia and CNS cancer | <50 | 199 | Ref. | Ref. | Ref. | 197 | Ref. | Ref. | Ref. | 187 | Ref. | Ref. | Ref. |
| | 50–100 | 377 | 1.10 (0.93–1.32) | 1.05 (0.88–1.26) | 1.04 (0.87–1.25) | 381 | 1.03 (0.87–1.23) | 0.99 (0.83–1.18) | 0.97 (0.81–1.16) | 391 | 0.99 (0.83–1.18) | 0.94 (0.79–1.13) | 0.93 (0.78–1.11) |
| | >100 | 272 | 1.26 (1.05–1.52) | 1.19 (0.99–1.44) | 1.19 (0.98–1.44) | 270 | 1.19 (0.99–1.43) | 1.15 (0.95–1.38) | 1.13 (0.93–1.36) | 270 | 1.15 (0.95–1.38) | 1.10 (0.91–1.32) | 1.08 (0.89–1.31) |
| Per 100 Bq m−3 | 1.09 (0.99–1.19) | 1.07 (0.98–1.17) | 1.07 (0.97–1.17) | 1.08 (0.99–1.18) | 1.08 (0.81–1.15) | 1.07 (0.97–1.17) | 1.07 (0.98–1.17) | 1.06 (0.96–1.16) | 1.06 (0.97–1.17) | ||||
Abbreviations: HR=hazard ratio; OR=odds ratio.
Model I is adjusted for socioeconomic status (family income, mother and father's level of education).
Model II is adjusted for all variables (parity, birth weight, sex, congenital malformations, family income, mother and father's level of education).
Grouped into five groups by increments of 100 Bq m−3.
Subanalyses of the associations between household radon concentration and childhood cancer by diagnostic group (adjusted HRs and 95% confidence interval) for children of age 0–15 years and born 1987 or later
| | ||||
|---|---|---|---|---|
| <50 | 30 | Ref. | 30 | Ref. |
| 50–100 | 77 | 0.89 (0.58–1.36) | 62 | 0.77 (0.49–1.21) |
| >100 | 55 | 1.00 (0.64–1.56) | 55 | 0.94 (0.58–1.51) |
| Per 100 Bq m−3 | 162 | 0.97 (0.78–1.20) | 147 | 1.04 (0.84–1.30) |
| <50 | 30 | Ref. | 30 | Ref. |
| 50–100 | 77 | 0.90 (0.58–1.40) | 62 | 0.75 (0.47–1.19) |
| >100 | 55 | 1.04 (0.66–1.65) | 55 | 0.92 (0.57–1.48) |
| Per 100 Bq m−3 | 162 | 0.98 (0.79–1.22) | 147 | 1.04 (0.83–1.30) |
| ⩽100 | 10 | Ref. | 7 | Ref. |
| >100 | 5 | 0.90 (0.31–2.66) | 6 | 2.33 (0.70–7.69) |
| 15 | 0.91 (0.54–1.55) | 13 | 1.36 (0.87–2.11) | |
| <50 | 49 | Ref. | 50 | Ref. |
| 50–100 | 118 | 0.99 (0.70–1.40) | 104 | 0.86 (0.60–1.22) |
| >100 | 69 | 0.99 (0.67–1.44) | 81 | 1.07 (0.74–1.55) |
| Per 100 Bq m−3 | 236 | 0.93 (0.76–1.13) | 235 | 1.09 (0.92–1.29) |
Abbreviations: CNS, central nervous system; HR, hazard ratio.
Grouped into five groups by increments of 100 Bq m−3.
Adjusted for parity, birth weight, sex, congenital malformations, family income, mother and father's level of education.
Distribution of 864 children with leukaemia or cancer in the CNS and corresponding person-years at risk across age in a population-based cohort of 712 674 children born in the Oslo region, Norway, in 1967–2009
| | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Male | 142 | 99 | 241 | 97 | 128 | 225 | 162 973 | 4 370 205 | 4 533 178 |
| Female | 123 | 73 | 196 | 95 | 107 | 202 | 151 905 | 4 171 404 | 4 323 309 |
| <35 | 215 | 153 | 368 | 166 | 194 | 360 | 234 614 | 5 900 368 | 7 547 476 |
| ⩾35 | 44 | 14 | 58 | 22 | 26 | 48 | 71 094 | 556 160 | 940 820 |
| No child | 109 | 65 | 174 | 88 | 87 | 175 | 37 695 | 3 564 454 | 3 670 691 |
| 1 Child | 86 | 58 | 144 | 63 | 82 | 145 | 44 070 | 2 940 098 | 3 057 787 |
| ⩾2 Children | 59 | 42 | 101 | 34 | 50 | 84 | 29 564 | 1 629 533 | 1 699 742 |
| <4000 | 203 | 127 | 330 | 151 | 177 | 328 | 249 615 | 6 659 616 | 6 909 231 |
| ⩾4000 | 56 | 39 | 95 | 37 | 43 | 80 | 55 668 | 1 512 785 | 1 568 453 |
| Yes | 23 | 7 | 30 | 23 | 13 | 36 | 16 999 | 278 497 | 295 496 |
| No | 242 | 165 | 407 | 169 | 222 | 391 | 297 879 | 8 263 112 | 8 560 991 |
| Yes | 9 | 7 | 16 | 2 | 8 | 10 | 5905 | 14 962 | 20 867 |
| No | 256 | 165 | 421 | 190 | 227 | 417 | 112 773 | 579 034 | 691 807 |
| Yes | 10 | 8 | 18 | 10 | 7 | 17 | 5441 | 23 879 | 29 320 |
| No | 255 | 164 | 419 | 182 | 228 | 410 | 113 237 | 570 117 | 683 354 |
| <10 | 62 | 44 | 106 | 34 | 58 | 92 | 53 826 | 2 007 801 | 2 061 627 |
| 10–12 | 99 | 68 | 167 | 72 | 91 | 163 | 82 480 | 3 274 549 | 3 357 029 |
| >12 | 97 | 58 | 155 | 80 | 84 | 164 | 160 468 | 3 058 493 | 3 218 961 |
| <10 | 56 | 36 | 92 | 41 | 46 | 87 | 53 780 | 1 828 921 | 1 882 701 |
| 10–12 | 102 | 79 | 181 | 71 | 95 | 166 | 97 632 | 3 411 785 | 3 509 417 |
| >12 | 96 | 54 | 150 | 72 | 90 | 162 | 142 101 | 3 022 737 | 3 164 838 |
| Low | 102 | 64 | 166 | 59 | 75 | 134 | 90 388 | 2 846 697 | 2 937 085 |
| Medium | 85 | 56 | 141 | 65 | 75 | 140 | 94 804 | 2 869 245 | 2 964 049 |
| High | 77 | 51 | 128 | 68 | 82 | 150 | 127 869 | 2 718 325 | 2 846 194 |
Abbreviations: CNS=central nervous system; HR, hazard ratio.